Clobetasol Related Published Studies
Well-designed clinical trials related to Clobetasol (Clobetasol Topical)
Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in
children: a randomized clinical trial. [2014]
A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05%
clobetasol propionate ointment in discoid lupus erythematosus by modified
cutaneous lupus erythematosus disease area and severity index. [2012]
A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo. [2011.09]
Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial. [2011.08]
Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis. [2011.08]
Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. [2011.07]
A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. [2011.06]
A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1%
vs. clobetasol propionate 0·05% in childhood vitiligo. [2011]
A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in
patients with vulvar lichen sclerosus. [2011]
Excimer laser vs. clobetasol propionate 0.05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot. [2010.10]
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis. [2010.05]
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis. [2010.01]
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. [2010.01]
Comparison of tape stripping with the human skin blanching assay for the bioequivalence assessment of topical clobetasol propionate formulations. [2010]
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. [2009.08.03]
Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis. [2009.03]
Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. [2009.03]
Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. [2009.02]
Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. [2009.01.08]
Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. [2009.01]
Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. [2008.12.26]
Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. [2008.09]
The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study. [2008.05]
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. [2008.03]
A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. [2008.02]
Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. [2007.05]
Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study. [2007.01]
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis. [2007]
Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. [2006.11]
A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. [2006.10]
Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial. [2006.09]
An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis. [2006.04]
Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis. [2006.04]
Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial. [2006.02]
Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. [2006.01]
A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. [2006]
Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. [2005.08]
Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream. [2005.05]
Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis. [2005.02]
Well-designed clinical trials possibly related to Clobetasol (Clobetasol Topical)
[Bullous pemphigoid: a review]. [2011.03]
Applicability of an exaggerated forearm wash test for efficacy testing of two corticosteroids, tacrolimus and glycerol, in topical formulations against skin irritation induced by two different irritants. [2011.02]
Dermasilk briefs in vulvar lichen sclerosus: an adjuvant tool. [2011]
The treatment of vulvar lichen sclerosus and female sexual dysfunction. [2011]
A new mucoadhesive dosage form for the management of oral lichen planus: formulation study and clinical study. [2010.11]
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. [2009.07]
A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study. [2009.01.29]
Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial. [2008.05]
Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. [2007.07]
Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. [2007.07]
Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. [2007.06]
Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers. [2007]
Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: Results of a randomized, double-blind, vehicle-controlled study. [2006.11]
Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial. [2006.10]
Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. [2006.08]
Prediction of survival for patients with bullous pemphigoid: a prospective study. [2005.06]
Highly potent and moderately potent topical steroids are effective in treating phimosis: a prospective randomized study. [2005.04]
Other research related to Clobetasol (Clobetasol Topical)
Topical delivery of clobetasol propionate loaded microemulsion based gel for
effective treatment of vitiligo--part II: rheological characterization and in
vivo assessment through dermatopharmacokinetic and pilot clinical studies. [2014]
The efficacy of clobetasol propionate with varying dilutions of emollient determined by histamine wheal suppression test. [2011.09]
The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata. [2011.07.25]
An open-label, multicenter study of the efficacy and safety of an AM/PM treatment regimen with clobetasol propionate spray 0.05% and calcitriol ointment 3 microg/g in the management of plaque psoriasis. [2011.07]
A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis. [2011.02]
Efficacy of clobetasol spray: Factors beyond patient compliance. [2011.01.22]
Management of two cases of desquamative gingivitis with clobetasol and Calendula officinalis gel. [2010.12]
Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markers. [2010.11]
Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice. [2010.11]
HPA-suppressive effects of aqueous clobetasol propionate in the treatment of patients with oral lichen planus. [2010.09]
Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis. [2010.08.01]
Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice. [2010.04]
Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. [2010.03.19]
Excimer laser vs. clobetasol propionate 0·05% ointment in prurigo form of atopic
dermatitis: a randomized controlled trial, a pilot. [2010]
Ultrasound evaluation of clobetasol propionate 0.05% foam application in psoriatic and healthy skin: a pilot study. [2009.11]
Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis. [2009.10]
The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison. [2009.08]
Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study. [2009.06.22]
Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis. [2009]
Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations. [2009]
Treatment of perniosis with oral pentoxyfylline in comparison with oral prednisolone plus topical clobetasol ointment in Iraqi patients. [2008.12]
Bone-anchored hearing aid abutment skin overgrowth reduction with clobetasol. [2008.12]
Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis. [2008.10.16]
Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses. [2008.08]
Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment. [2008.08]
Clobetasol propionate--where, when, why? [2008.07]
Clobetasol propionate emulsion formulation foam 0.05%: Review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. [2008.06.06]
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses. [2008.06]
The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study. [2008.02.12]
In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle. [2008.01]
Bioequivalence assessment of topical clobetasol propionate products using visual and chromametric assessment of skin blanching. [2008]
Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis. [2008]
Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial. [2007.11]
Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial. [2007.11]
Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus. [2007.03]
Evaluation of the effects of topical clobetasol propionate by visual score, electrical impedance and laser Doppler flowmetry. [2007.02]
Topical testosterone versus clobetasol for vulvar lichen sclerosus. [2007.02]
Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia. [2007]
Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis. [2006.11]
Clobetasol propionate for psoriasis: are ointments really more potent? [2006.06]
Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques. [2006.01]
Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB. [2005.11]
Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. [2005.09]
Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients. [2005.09]
Clobetasol propionate foam in the treatment of psoriasis. [2005.08]
|
